Objectives: To evaluate outcomes of patients achieving a post-treatment pathological stage of

Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration / Ravi, P.; Pond, G. R.; Diamantopoulos, L. N.; Su, C.; Alva, A.; Jain, R. K.; Skelton, W. P.; Gupta, S.; Tward, J. D.; Olson, K. M.; Singh, P.; Grunewald, C. M.; Niegisch, G.; Lee, J. -L.; Gallina, A.; Bandini, M.; Necchi, A.; Mossanen, M.; Mcgregor, B. A.; Curran, C.; Grivas, P.; Sonpavde, G. P.. - In: BJU INTERNATIONAL. - ISSN 1464-4096. - (2021). [10.1111/bju.15434]

Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration

Bandini M.;Necchi A.;
2021-01-01

Abstract

Objectives: To evaluate outcomes of patients achieving a post-treatment pathological stage of
2021
#BladderCancer
#blcsm
bladder cancer
neoadjuvant chemotherapy
pathological response
recurrence
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/118323
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 13
social impact